News summary

Kentucky bars compounding of the six peptides HHS allowed in October

Source: Longevity Docs News • Published: 20 Nov 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

Kentucky blocked compounding and shipping of six HHS-listed peptides for patients.

Kentucky bars compounding of the six peptides HHS allowed in October
Key Takeaways
  • Kentucky pharmacists were ordered to stop compounding the six peptides.
  • The federal HHS nonenforcement policy was not found to preempt state law.
  • Clinical efficacy in humans for these peptides remains limited and unproven.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?MoL PickLongevity is leaving the clinicStephen Watson argues that hotels, gyms and residential communities can build longevity memberships around the relationships they already have.MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.